Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Experts call for stronger regulation of digital food marketing to counter the increasing risk for obesity and teens’ ...

Researchers have discovered that tirzepatide and semaglutide impact energy metabolism in distinct ways. New animal research ...

The "Make America Healthy Again" report, commissioned by President Trump, highlights ultraprocessed foods and environmental ...

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...

A report published in November by KFF, a health information nonprofit that includes KFF Health News, found only 13 states were covering GLP-1s for the treatment of obesity for Medicaid beneficiaries ...

Health and Human Services Secretary Robert F. Kennedy’s “Make America Healthy Again” report calls for increased scrutiny of ...

Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look ...

The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

How a new Trump plan could make science ‘a political football’ The NIH is already in turmoil. Billlions of dol ...

Adults with obesity using a GLP-1 have a similar risk for obesity-related cancers as those who undergo bariatric surgery, ...

FRIDAY, May 23, 2025 (HealthDay News) — A new White House report says today’s children are the sickest generation in U.S.